Skip to content
POM-V Prescription Required Companion Animal

Anaestamine 100 mg/ml Solution for Injection

Active ingredient: Ketamine

Form

Injection

Species

Cats Cattle Dogs Goats Guinea Pig Hamster Horses Mouse Pigs Rabbits Rat Sheep

Manufacturer

Le Vet Beheer B.V.

VMD MA No.

41821/4011

What it's used for

The product may be used in combination with a sedative for: - Immobilisation - Sedation - General anaesthesia

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Ketamine

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Anaestamine 100 mg/ml Solution for Injection — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 18 Mar 2026.

The product may be used in combination with a sedative for:
- Immobilisation
- Sedation
- General anaesthesia
For intravenous and intramuscular use.
In laboratory animals, intraperitoneal use is also possible. Ketamine should be
combined with a sedative.
One dose of 10 mg of ketamine per kg bodyweight corresponds to 0.1 ml of a 100
mg/ml solution per kg bodyweight.
Ketamine can show large inter-individual variation in effect, and therefore dose rates
administered should be tailored to the individual animal, dependent on factors such
as age, condition, and the depth and duration of anaesthesia required.
Before ketamine is administered, please ensure that the animals are adequately
sedated.
DOG
Combination with xylazine or medetomidine
Xylazine (1.1 mg/kg IM) or medetomidine (10 to 30 µg/kg IM) can be used with
Ketamine (5 to 10 mg/kg i.e. 0.5 to 1 ml/10 kg IM) for short term anesthesia of 25 to
40 min. The ketamine dose can be adjusted, depending on the desired duration of
surgery.
CAT
Combination with xylazine
Xylazine (0.5 to 1.1 mg/kg IM) with or without atropine is administered 20 min before
ketamine (11 to 22 mg/kg IM i.e. 0.11 to 0.22 ml/kg IM).

Revised: August 2019
AN: 01376/2018
Combination with medetomidine
Medetomidine (10 to 80 µg/kg IM) can be combined with ketamine (2.5 to 7.5 mg/kg
IM i.e 0.025 to 0.075ml/kg IM). The dose of ketamine should be reduced as the dose
of medetomidine increases.
HORSE
Combination with detomidine:
Detomidine 20 µg/kg IV, after 5 minutes ketamine 2.2 mg/kg fast IV (2.2 ml/100 kg
IV)
Onset of action is gradual, taking approximately 1 minute to attain recumbency, with
duration of anaesthetic effect lasting approximately 10 - 15 minutes.
Combination with xylazine:
Xylazine 1.1 mg/kg IV, followed by ketamine 2.2 mg/kg IV (2.2 ml/100 kg IV)
Onset of action is gradual, taking approximately 1 minute, with duration of
anaesthetic effect being variable and lasting 10 - 30 minutes but usually less than 20
minutes.
After injection the horse lays down spontaneously without any further help. If a
distinct muscle relaxation is required simultaneously, muscle relaxants can be
administered to the recumbent animal, until the horse shows first symptoms of
relaxation.
CATTLE
Combination with xylazine:
Adult cattle can be anesthetized for short periods with xylazine (0.1 to 0.2 mg/kg IV)
followed by ketamine (2 mg/kg IV i.e. 2 ml/100kg IV). The lower dose of xylazine is
used when cattle weigh more than 600 kg. Anesthesia Iasts approximately 30 min but
can be pro-longed for 15 min with additional ketamine (0.75 to 1.25 mg/kg IV i.e. 0.75
to 1.25 ml/100kg IV).
SHEEP
Ketamine 7.5 to 22 mg/kg IV i.e. 0.75 to 2.2 ml/10kg IV depending on the sedative
used.
GOAT
Ketamine 11 to 22 mg/kg IM i.e. 1.1 to 2.2 ml/10kg IM depending on the sedative
used.
PIG
Combination with azaperone:
Ketamine 15 - 20 mg/kg IM (1.5 - 2 ml/10 kg) and 2 mg/kg azaperone IM.
In 4 – 5 month old pigs, following administration of 2 mg/kg azaperone and 20 mg/kg
ketamine IM, the onset of anaesthesia took on average 29 minutes and duration of
effect lasted about 27 minutes.
LABORATORY ANIMALS
Combination with xylazine
Rabbits: xylazine (5-10 mg/kg IM) + ketamine (35-50 mg/kg IM i.e. 0.35 to 0.50 ml/kg
IM)
Rats: xylazine (5-10 mg/kg IP, IM) + ketamine (40-80 mg/kg IP, IM i.e. 0.4-0.8 ml/kg
IP, IM)
Mice: xylazine (7.5-16 mg/kg IP) + ketamine (90-100 mg/kg IP i.e. 0.9 to 1.0 ml/kg IP)

Revised: August 2019
AN: 01376/2018
Guinea pigs: xylazine (0.1 to 5 mg/kg IM) + ketamine (30-80 mg/kg IM i.e. 0.3 to 0.8
ml/kg IM)
Hamster: xylazine (5 to 10 mg/kg IP) + ketamine (50 to 200 mg/kg IP i.e. 0.5 to 2
ml/kg IP)
Dose for maintenance of anaesthesia:
When needed prolongation of effect is possible by repeated administration of an
optionally reduced initial dose.
The vial can be broached up to 20 times. The user should choose the most
appropriate vial size according to the target species to be treated and the
administration route.
Do not use in animals presenting with:
- severe hypertension,
- cardio-respiratory deficiency,
- hepatic or renal dysfunction.

Revised: August 2019
AN: 01376/2018
Do not use in animals with glaucoma.
Do not use in animals with eclampsia or pre-eclampsia.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Do not use the product as a sole anaesthetic agent in any of the target species.
Do not use for surgical intervention on pharynx, larynx, trachea or bronchial tree, if
sufficient relaxation is not ensured by administration of a muscle relaxant (intubation
obligatory).
Do not use in ocular surgical interventions.
Do not use in animals undergoing a myelogram procedure.
Do not use in patients with pheochromocytoma or untreated hyperthyroidism.
Emergence reactions - ataxia, hypersensitivity to stimuli, excitation – have been
reported in horses and dogs rarely and very rarely respectively.
Salivation in cats has been reported very rarely.
Increased tonus of skeletal muscles in cats, dogs, horses, rabbits, cattle and goats
has been reported very rarely.
Dose-related respiratory depression, which may lead to respiratory arrest in cats,
dogs, rabbits, cattle and goats has been reported very rarely Combination with
respiratory depressant products may increase this respiratory effect.
Increased heart rate in cats and dogs has been reported very rarely.
Increased arterial blood pressure with concurrent increased bleeding tendency in
dogs has been reported very rarely.
Eyes that remain open with mydriasis and nystagmus have been reported in cats
very rarely
.
Pain on intramuscular injection in cats has been reported very rarely.
All adverse reactions and frequencies are from spontaneous reports.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).>
For very painful and major surgical interventions, as well as for maintenance of
anaesthesia, a combination with injectable or inhalation anaesthetics is necessary.
As muscle relaxation required for surgical procedures cannot be achieved with
ketamine alone, additional muscle-relaxants should be used concomitantly. For
improvement of anaesthesia or prolongation of effect ketamine can be combined with
α2-receptor- agonists, anaesthetics, neuroleptanalgesics, tranquilizers and
inhalational anaesthetic agents.

Special precautions for use in animals
A small proportion of animals have been reported to be unresponsive to ketamine as
an anaesthetic agent at normal dosages. Use of premedicants should be followed by
a suitable reduction in dosage.
In the cat and dog, the eyes remain open and the pupils dilated. The eyes may be
protected by covering with a damp gauze swab or using appropriate ointments.
Ketamine may exhibit pro-convulsant and anti-convulsant properties, and therefore
should be used with care in patients with seizure disorders.
Ketamine may increase intracranial pressure and therefore, may not be suitable for
patients with cerebrovascular insults.
When used in combination with other products, consult the contraindications and
warnings that appear on the relevant data sheets.
The eyelid reflex stays intact.
Twitching, as well as excitation upon recovery, may be possible. It is important that
both premedication and recovery should occur in quiet and calm surroundings. To
ensure a smooth recovery appropriate analgesia and premedication should be
administered, if indicated.
The concomitant use of other pre-anaesthetics or anaesthetics should be subject to a
benefit/risk assessment, taking into account the composition of the used medicines
and their doses and the nature of the intervention. The recommended doses of
ketamine are likely to vary depending on the concomitant pre-anaesthetics and
anaesthetics used.
The prior administration of an anticholinergic such as atropine or glycopyrrolate to
prevent the occurrence of adverse effects, especially hypersalivation, may be
considered after a benefit/risk assessment by the veterinarian.
Ketamine should be used with caution when pulmonary disease is present or
suspected.

Revised: August 2019
AN: 01376/2018
In small rodents cooling down should be prevented.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
This is a potent drug. Particular care should be taken to avoid accidental self-
administration.
People with known hypersensitivity to ketamine or any of the excipients should avoid
contact with the veterinary medicinal product.
Avoid contact with the skin and eyes. Wash any splashes from skin and eyes
immediately with large amounts of water.
Adverse effects on the foetus cannot be excluded. Pregnant women should avoid
handling the product.
In case of accidental self-injection or if symptoms occur after ocular/oral contact,
seek medical advice immediately and show the package leaflet or the label to the
physician, but DO NOT DRIVE.
To the physician:Do not leave patient unattended. Maintain airways and give
symptomatic and supportive treatment.
Neuroleptics, tranquillisers, cimetidine and chloramphenicol potentiate ketamine
anaesthesia (also seesection 4.4).
Barbiturates, opiates and diazepam may prolong the recovery time.
Effects may be potentiated. A decrease of the dose of one or both agents may be
necessary.
There is a possibility of an increased risk of cardiac arrhythmia when ketamine is
used in combination with thiopental or halothane. Halothane prolongs the half-life of
ketamine.
The simultaneous intravenous administration of a spasmolytic agent may provoke a
collapse.
Theophylline, when given with ketamine, may provoke an increase of epileptic crises.
When detomidine is used together with ketamine, the recovery is slower than when
ketamine is used alone.
Excipient(s):
Chlorocresol 1 mg
For the full list of excipients, see section

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.